Some trials with IFN as a therapy have resulted in unwanted local inflammation and side effects.51 In certain systems, IFN is known to induce inflammation.52 As a therapy for inflammatory disorders such as asthma and COPD, creating further inflammation in the absence of infection may be detrimental rather than beneficial. This evidence concerns the gene IFNA1 and asthma.